Yves Horsmans

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

HLA association of amoxicillin-clavulanate–induced hepatitis

M. Hautekèete, Yves Horsmans, C. Van Waeyenberge et al. · Gastroenterology · 1999 · 280 citations

Antibiotics, Hla Association, Viral Hepatitis +4

Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice

Isabelle Leclercq, Geoffrey C. Farrell, Christine Sempoux et al. · Journal of Hepatology · 2004 · 217 citations

Inflammation, Anti-inflammatory, Hepatology +10

A Pilot Study of Therapeutic Vaccination With Envelope Protein E1 in 35 Patients With Chronic Hepatitis C

Frederik Nevens, Tania Roskams, Hans Van Vlierberghe et al. · Hepatology · 2003 · 133 citations